FindTrial
Sign In

NIFEdipine ER

DRUG7 trials

Sponsors

Brigham and Women's Hospital, Prisma Health-Upstate, The University of Texas Health Science Center, Houston, Nebraska Methodist Health System, Queen Mary University of London

Conditions

Endocrine HypertensionGestational HypertensionHypertension in PregnancyHypertension, Pregnancy-InducedHypertensive Disorder of PregnancyPostpartumPostpartum PreeclampsiaPreeclampsia Severe

Phase 3

Intensive Postpartum Antihypertensive Treatment
Active, not recruitingNCT05687344
Medical College of WisconsinHypertensive Disorder of Pregnancy
Start: 2023-09-01End: 2026-08-30Target: 60Updated: 2026-07-20

Phase 4

Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period
CompletedNCT04236258
Brigham and Women's HospitalGestational Hypertension, Hypertension in Pregnancy, Postpartum +2
Start: 2020-01-24End: 2021-06-30Updated: 2022-11-30
Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension
CompletedNCT04790279
Prisma Health-UpstateHypertension in Pregnancy
Start: 2021-04-09End: 2023-01-25Updated: 2024-10-28
Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension
CompletedNCT05049616
The University of Texas Health Science Center, HoustonHypertension in Pregnancy, Postpartum Preeclampsia
Start: 2021-10-18End: 2023-09-01Updated: 2025-11-07
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
RecruitingNCT05309460
Nebraska Methodist Health SystemHypertension in Pregnancy, Postpartum Preeclampsia
Start: 2022-06-20End: 2024-12-01Target: 600Updated: 2024-04-12

Unknown Phase

Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism
CompletedNCT05686993
Queen Mary University of LondonEndocrine Hypertension, Primary Aldosteronism
Start: 2023-04-24End: 2023-09-06Updated: 2024-07-08
Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia
RecruitingNCT06220721
Medical College of WisconsinHypertension, Pregnancy-Induced
Start: 2024-10-23End: 2029-06-30Target: 618Updated: 2026-07-20

Related Papers

Evaluation of Aldosterone Suppression by Cinnarizine, a Putative Cav1.3 Inhibitor.
2025-09-012 citations
Amlodipine versus nifedipine ER for the management of postpartum hypertension: a noninferiority randomized controlled trial.
2024-12-092 citations
Intensive postpartum antihypertensive treatment (IPAT) and healthy lifestyle education: Study protocol for a pilot randomized controlled trial for patients with hypertensive disorders of pregnancy.
2024-10-10
A randomized controlled trial comparing the efficacy of nifedipine and enalapril in the postpartum period.
2023-10-064 citations